Figure 6
Figure 6. Anti–myosin antibody–induced reduction of thrombin peak values observed for acute trauma coagulopathy plasma and normal control plasma following tissue factor/Ca++ ion addition. The effects of anti–myosin antibodies on the 0.1-pM TF-induced peak of thrombin generation in plasmas from acute traumatic coagulopathy patients (N = 26) and healthy controls (N = 20) were tested using either polyclonal antiserum against myosin heavy and light chains or nonimmune control antiserum, respectively (2 mg/mL protein). The graphs show the reduction of thrombin peak values by anti-myosin antibodies either as percent of control peak (A) or in absolute concentration of the thrombin peak (B). Bars indicate median values.

Anti–myosin antibody–induced reduction of thrombin peak values observed for acute trauma coagulopathy plasma and normal control plasma following tissue factor/Ca++ ion addition. The effects of anti–myosin antibodies on the 0.1-pM TF-induced peak of thrombin generation in plasmas from acute traumatic coagulopathy patients (N = 26) and healthy controls (N = 20) were tested using either polyclonal antiserum against myosin heavy and light chains or nonimmune control antiserum, respectively (2 mg/mL protein). The graphs show the reduction of thrombin peak values by anti-myosin antibodies either as percent of control peak (A) or in absolute concentration of the thrombin peak (B). Bars indicate median values.

Close Modal

or Create an Account

Close Modal
Close Modal